Advertisement

U.S. markets open in 12 minutes

S&P Futures
3,922.00
+18.25(+0.47%)
Dow Futures
31,590.00
+169.00(+0.54%)
Nasdaq Futures
12,080.25
+39.75(+0.33%)
Russell 2000 Futures
1,782.60
+12.80(+0.72%)
Crude Oil
111.25
+1.68(+1.53%)
Gold
1,823.90
-0.90(-0.05%)

Advertisement

Acurx Pharmaceuticals, Inc. (ACXP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

3.6999

+0.0099

(+0.27%)

At close: 04:00PM EDT

3.8000

+0.10

(+2.71%)

Pre-Market:

08:39AM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Momentum

View all chart patterns

Performance Outlook

Previous Close	3.6900
Open	3.8200
Bid	3.3600 x 900
Ask	3.7900 x 1000
Day's Range	3.6500 - 3.8200
52 Week Range	2.3300 - 7.0000
Volume	4,845
Avg. Volume	15,775

Market Cap	37.973M
Beta (5Y Monthly)	N/A
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ACXP

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Acurx Pharmaceuticals, Inc.
Analyst Report: Merck & Co., Inc.Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Rating
Fair Value
Economic Moat
7 days agoMorningstar